VYOME HOLDINGS, INC.

HIND ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $319.7K $256.9K $8.7M $11.2M $13.6M $11.3M $3.3M
Cost of Revenue $100.9K $62.0K $3.1M $4.4M $5.3M $5.0M $3.0M
Gross Profit $218.8K $195.0K $5.5M $6.8M $8.3M $6.3M $331.0K
Gross Margin 68.4% 75.9% 63.9% 60.5% 61.4% 55.4% 10.1%
Operating Expenses
Research & Development $588.3K $285.4K $2.3M $2.5M $2.4M $3.5M $6.9M
SG&A Expense $2.4M $898.6K $7.5M $14.1M $8.9M $4.7M $16.7M
Operating Income $-10.5M $-1.0M $-15.4M $-46.4M $-57.9M $-12.5M $-23.2M
Operating Margin -3,269.4% -391.7% -177.3% -412.4% -425.6% -110.2% -708.0%
Interest Expense
Pretax Income $-7.1M $-11.3M $-46.6M $-63.4M $-21.8M
Income Tax Expense $39.0K $52.0K $-380.0K $-274.0K $-181.0K $14.0K
Net Income $-10.3M $-1.4M $-11.4M $-46.2M $-63.1M $-21.6M $-23.7M
Net Margin -3,209.7% -563.3% -131.2% -411.2% -464.3% -191.4% -721.6%
EPS (Basic) $-4.86 $-1,500.35 $-5.54 $-5.45 $-14.45 $-0.28 $-0.25
EPS (Diluted) $-4.86 $-1,500.35 $-5.54 $-5.45 $-14.45 $-0.28 $-0.25
Shares Outstanding (Basic) 7.0M 2.2M 2.1M 2.1M 8.5M 4.4M 78.1M 154.5M
Shares Outstanding (Diluted) 7.0M 2.2M 2.1M 2.1M 8.5M 4.4M 78.1M 154.5M
Dividends Per Share
← Newer Page 1 of 2 Older →